IL102859A - Phosphoineositol-glycene-peptide with insulin-like activity and its preparation - Google Patents

Phosphoineositol-glycene-peptide with insulin-like activity and its preparation

Info

Publication number
IL102859A
IL102859A IL10285992A IL10285992A IL102859A IL 102859 A IL102859 A IL 102859A IL 10285992 A IL10285992 A IL 10285992A IL 10285992 A IL10285992 A IL 10285992A IL 102859 A IL102859 A IL 102859A
Authority
IL
Israel
Prior art keywords
glycan
phosphoinositol
peptide
insulin
binding protein
Prior art date
Application number
IL10285992A
Other languages
English (en)
Hebrew (he)
Other versions
IL102859A0 (en
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL102859A0 publication Critical patent/IL102859A0/xx
Publication of IL102859A publication Critical patent/IL102859A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
IL10285992A 1991-08-20 1992-08-18 Phosphoineositol-glycene-peptide with insulin-like activity and its preparation IL102859A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4127495 1991-08-20

Publications (2)

Publication Number Publication Date
IL102859A0 IL102859A0 (en) 1993-01-31
IL102859A true IL102859A (en) 1998-12-27

Family

ID=6438668

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10285992A IL102859A (en) 1991-08-20 1992-08-18 Phosphoineositol-glycene-peptide with insulin-like activity and its preparation

Country Status (22)

Country Link
US (1) US5624903A (sh)
EP (1) EP0532915B1 (sh)
JP (1) JP3361126B2 (sh)
KR (2) KR100264623B1 (sh)
AT (1) ATE147407T1 (sh)
AU (1) AU656396B2 (sh)
CA (1) CA2076424C (sh)
CZ (1) CZ290341B6 (sh)
DE (1) DE59207835D1 (sh)
DK (1) DK0532915T3 (sh)
ES (1) ES2096686T3 (sh)
FI (1) FI102842B (sh)
GR (1) GR3022895T3 (sh)
HR (1) HRP940834B1 (sh)
HU (1) HU210431B (sh)
IL (1) IL102859A (sh)
NO (1) NO303452B1 (sh)
SG (1) SG46639A1 (sh)
SK (1) SK281333B6 (sh)
TW (1) TW224104B (sh)
YU (1) YU66892A (sh)
ZA (1) ZA926232B (sh)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE184611T1 (de) * 1991-11-29 1999-10-15 Hoechst Ag Peptide mit insulinartiger wirkung
ES2159283T3 (es) * 1992-02-29 2001-10-01 Aventis Res & Tech Gmbh & Co Complejos que contienen glicosil-fosfatidilinositol-proteinas y derivados de acido colanico, procedimiento para su preparacion y su utilizacion.
US5652221A (en) * 1994-11-07 1997-07-29 The University Of Virginia Patent Foundation Method of treating defective glucose metabolism using synthetic insulin substances
GB9618929D0 (en) 1996-09-11 1996-10-23 Univ London Metal containing carbohydrates from human tissue which regulate glycogen metabolism
GB9618934D0 (en) * 1996-09-11 1996-10-23 Univ London Inositol phosphoglycans for therapeutic use in the treatment of diabetes and obesity
GB9618930D0 (en) 1996-09-11 1996-10-23 Univ London Metal containing carbohydrates from human tissue which regulate lipogenic activity
DE19649350A1 (de) * 1996-11-28 1998-06-04 Hoechst Ag Inositolglykane mit insulinartiger Wirkung
KR100481746B1 (ko) * 1996-11-28 2005-08-10 훽스트 악티엔게젤샤프트 인슐린-유사작용을갖는이노시톨글리칸및이를포함하는약제학적제제
EP2158923B1 (en) 1998-08-06 2013-02-27 Mountain View Pharmaceuticals, Inc. Peg-urate oxidase conjugates and use thereof
CH697081A5 (de) * 2002-01-22 2008-04-30 Andreas F Dr Schaub Zusammensetzung für die Unterstützung der Geburt eines menschlichen Föten.
EP1378517A1 (en) * 2002-07-05 2004-01-07 Aventis Pharma Deutschland GmbH Phosphoinositolglycan (PIG) binding protein from adipocytes
CA2491555C (en) * 2002-07-10 2012-09-11 Massachusetts Institute Of Technology Solid-phase and solution-phase synthesis of glycosylphosphatidylinositol glycans
ITMI20030237A1 (it) * 2003-02-11 2004-08-12 Indena Spa Uso della conglutina di lupino per il trattamento del
DE102004054552A1 (de) * 2004-11-11 2006-05-18 Hcb Happy Child Birth Holding Ag Neue Zusammensetzung zur Erleichterung der Humangeburt
RU2435847C2 (ru) 2005-04-11 2011-12-10 Савиент Фармасьютикалз, Инк. Вариантная форма урат-оксидазы и ее использование
PL3321359T3 (pl) 2005-04-11 2021-06-28 Horizon Pharma Rheumatology Llc Wariantowe postacie oksydazy moczanowej i ich zastosowanie
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
KR101861547B1 (ko) 2009-06-25 2018-07-02 크레알타 파마슈티칼스 엘엘씨 페길화된 유리카아제 치료 중에 혈청 요산을 모니터링하여 주입 반응의 위험성 및 반응의 항체­매개 상실을 예측하는 방법 및 키트
CN102270762B (zh) * 2010-06-03 2014-08-20 清华大学 锂离子电池电极浆料及应用该电极浆料制备的电极片

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
DE3326472A1 (de) * 1983-07-22 1985-02-14 Hoechst Ag, 6230 Frankfurt Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
US4906468A (en) * 1986-04-11 1990-03-06 The Rockefeller University Insulin activity messengers, their antibodies, and thereof
US4839466A (en) * 1986-04-11 1989-06-13 The Rockefeller University Insulin activity messengers

Also Published As

Publication number Publication date
ATE147407T1 (de) 1997-01-15
SG46639A1 (en) 1998-02-20
NO923252L (no) 1993-02-22
AU656396B2 (en) 1995-02-02
AU2110992A (en) 1993-02-25
DE59207835D1 (de) 1997-02-20
FI923702A (fi) 1993-02-21
EP0532915B1 (de) 1997-01-08
JP3361126B2 (ja) 2003-01-07
HRP940834B1 (en) 2000-08-31
CA2076424A1 (en) 1993-02-21
GR3022895T3 (en) 1997-06-30
NO303452B1 (no) 1998-07-13
JPH05301891A (ja) 1993-11-16
EP0532915A2 (de) 1993-03-24
FI923702A0 (fi) 1992-08-18
YU66892A (sh) 1995-10-24
IL102859A0 (en) 1993-01-31
HUT62013A (en) 1993-03-29
DK0532915T3 (da) 1997-07-07
TW224104B (sh) 1994-05-21
ZA926232B (en) 1993-04-28
CZ255392A3 (en) 1993-03-17
CZ290341B6 (cs) 2002-07-17
KR100318706B1 (ko) 2001-12-28
ES2096686T3 (es) 1997-03-16
HRP940834A2 (en) 1997-04-30
EP0532915A3 (en) 1994-05-18
SK255392A3 (en) 1995-02-08
FI102842B1 (fi) 1999-02-26
NO923252D0 (no) 1992-08-19
FI102842B (fi) 1999-02-26
KR930004327A (ko) 1993-03-22
SK281333B6 (sk) 2001-02-12
CA2076424C (en) 2003-06-03
US5624903A (en) 1997-04-29
KR100264623B1 (ko) 2000-09-01
HU210431B (en) 1995-04-28

Similar Documents

Publication Publication Date Title
CA2076424C (en) Phosphoinositol-glycan-peptide with insulin-like action
Ogata et al. Chemical characterization of the membrane-anchoring domain of human placental alkaline phosphatase.
Cohen et al. Isolation and characterization of renin-like enzymes from mouse submaxillary glands
Verger et al. Novel intestinal phospholipase A2: purification and some molecular characteristics
Bause et al. Enzymatic N‐glycosylation and O‐glycosylation of synthetic peptide acceptors by dolichol‐linked sugar derivatives in yeast
Jolles Relationship between chemical structure and biological activity of hen egg-white lysozyme and lysozymes of different species
Lu et al. Primary structure of human triosephosphate isomerase.
Herring Methods for the study of the glycoproteins and proteoglycans of bone using bacterial collagenase: Determination of bone sialoprotein and chondroitin sulphate
Tsuru et al. Studies on Bacterial Protease: Part XVIII. Proteolytic Specificity of Neutral Protease of Bacillus subtilis var. amylosacchariticu s
Koolman et al. 26-Hydroxyecdysone, 20, 26-dihydroxyecdysone and inokosterone detected as metabolites of ecdysone in the blowfly Calliphora vicina by radiotracer experiments
Takahashi et al. Acyl intermediates in pepsin and penicillopepsin catalyzed reactions
Ishihara et al. Isolation and characterization of fucose sulfate from jelly coat glycoprotein of sea urchin egg
JPH0536034B2 (sh)
Sharma et al. Partial purification of a mannosyltransferase involved in the O-mannosylation of glycoproteins from Saccharomyces cerevisiae
Sugawara ε-(γ-Glutamyl) lysine Cross-link in the Terminal Differentiation of Mammalian Epidermis
Matsumoto et al. Acylation of lysophospholipids including lysoplasmalogen by cultured human amnion cells (FL cells)
Brdiczka et al. Mitochondrial matrix granules in soft tissues: II. Isolation and initial characterization of a calcium-precipitable, soluble lipoprotein subfraction from brown fat and liver mitochondria
Jonczyk et al. Preparation and biological properties of [LeuB24, LeuB25] human insulin
Gavrilova et al. Phospholipid-dependence of rat liver plasma membrane protein kinase activities—a new approach
Chin et al. Studies on Nα-acylated proteins: The N-terminal sequences of two muscle enolases
Maler et al. Isolation and characterization of the plasma membranes of cultured lymphoblasts from patients with cystic fibrosis and normal individuals
Kawata et al. Characterization of d-Alanyl-(d)-meso-2, 6-diaminopimelic Acid Endopeptidase from Streptomyces globisporus 1829
Fujii et al. Asparagine-linked carbohydrate of Penicillium notatum phospholipase B
de Médicis et al. The halophilic properties of pyruvate kinase from Vibrio costicola, a moderate halophile
Wielgus Stimulation of intermoult cuticle deposition by a haemolymph trophic factor in the tobacco hornworm, Manduca sexta

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees